48,466
edits
(→Follicular neoplasm: +comment on molecular) |
|||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
== Malignant == | |||
<pre> | |||
Left Thyroid, FNA: Malignant. (Category VI) | |||
Cellular aspirate. | |||
Malignant cells present with papillary fragments, powdery chromatin, nuclear grooves, intranuclear cytoplasmic pseudoinclusions, multinucleated giant cells and psammoma bodies consistent with papillary thyroid carcinoma. | |||
</pre> | |||
== Suspicious for malignancy == | == Suspicious for malignancy == | ||
<pre> | <pre> | ||
Line 17: | Line 26: | ||
Follicular cells with a predominantly microfollicular and syncytial architecture, scattered isolated cells, and colloid. Correlation of cytological findings with radiological and clinical findings is warranted. | Follicular cells with a predominantly microfollicular and syncytial architecture, scattered isolated cells, and colloid. Correlation of cytological findings with radiological and clinical findings is warranted. | ||
</pre> | |||
===Molecular testing may be considered=== | |||
<pre> | |||
The impression on imaging and the ACR TI-RADS are noted. | |||
The differential diagnosis includes (benign) adenomatoid nodule, follicular adenoma and follicular carcinoma. Molecular testing (not available in house) would be a fair and reasonable consideration. The cell block has moderate cellularity; it likely has sufficient tissue. | |||
</pre> | </pre> | ||
edits